The abstract is read at the publisher; the summary is JClub's.
Robotic pancreatoduodenectomy is linked to similar major complications (34% vs 32%) but a faster median functional recovery by 2 days versus open surgery in 4 RCTs.
- Why it matters: Randomized trials may miss low-frequency outcomes and subgroup differences, leaving uncertainty about which patients benefit from robotic pancreatoduodenectomy.
- What they did: A systematic review and individual patient data meta-analysis pooled four randomized controlled trials (745 patients) from 25 experienced, high-volume centres across seven countries, comparing major complications (Clavien-Dindo ≥3) and modified time to functional recovery.
- The result: Major complications were 140/407 after robotic versus 106/329 after open (adjusted risk difference -2% [95% CI -7 to 3], p adjusted =0·37), while median mTTFR was 9 days (IQR 6–14) versus 12 days (7–15) (adjusted median difference -2 [95% CI -3 to -1], p adjusted <0·0001).
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.